By Steven Reinberg HealthDay Reporter WEDNESDAY, July 20, 2022 (HealthDay News) — Hormone substitute remedy (HRT) for breast most cancers survivors would not seem to extend the danger of most cancers recurrence or dying, Danish researchers report. Although HRT has beforehand been linked to a raised danger of breast most cancers’s return, these earlier research […]